Includes nurse practitioners as a provider of services for purposes of collaborative drug therapy management; makes the authorization for pharmacists to perform such management permanent.
Permits midwives and physician assistants to certify the cause of death on a fetal death certificate if they are in attendance at or after a fetal death.